Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...

Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled ... disease (COPD) Afrezza is ...

Prescription and OTC weight loss medications are available, but only one nonprescription medication has Food and Drug Administration (FDA) approval. This article discusses what weight loss ...

Dec. 16, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with ...

This could be a hard pill to swallow. Now, a board-certified anesthesiologist in Los Angeles is revealing five daily medications that may also increase your likelihood of developing dementia ...

“Pharmaceutical companies should not be able to use reformulating as an excuse to sidestep their promises to patients.” Twenty-five million Americans with asthma and 16 million Americans with COPD ...

Ototoxicity is an adverse effect of some drugs. It is a condition that occurs when the inner ear is damaged by certain medications or chemicals, causing hearing problems or tinnitus (ringing in the ...